Tesla shares down following National Highway Traffic Safety Administration investigation into Autopilot feature Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- CureVac (CVAC) up 9% after announcing preclinical data investigating immune responses as well as the protective efficacy of CureVac's first-generation vaccine candidate, CVnCoV, and second-generation vaccine candidate, CV2CoV, against SARS-CoV-2 showed improved immune responses
- ADMA Biologics (ADMA) up 14% after announcing that it has received FDA approval for its ADMA BioCenters plasma collection facility located in Maryville, Tennessee
- Rocket Pharmaceuticals (RCKT) up 1% after announcing that the FDA has lifted the clinical hold on the company's Phase 1 clinical trial of RP-A501 for the treatment of Danon Disease, allowing patient enrollment to resume
UP AFTER EARNINGS -
- Oatly Group (OTLY) up 2%
- Taysha Gene Therapies (TSHA) up 4%
DOWN AFTER EARNINGS -
- Paysafe (PSFE) down 9%
- DouYu (DOYU) down 1%
- Vermilion Energy (VET) down 2%
- Brooklyn ImmunoTherapeutics (BTX) down 4%
- UWM Holdings (UWMC) down 6%
LOWER -
- Tesla (TSLA) down 2% after The National Highway Traffic Safety Administration opened a formal safety investigation that covers 765,000 models Y, X, S and 3 for years 2014 through 2021
Symbols:
CVAC ADMA RCKT OTLY TSHA PSFE DOYU VET BTXBrooklyn ImmunoTherapeutics
UWMC TSLA Keywords: Fly Intel, Wall Street, Top Stories, Stocks